Nothing new today — and a gap filled: the 2026 Surviving Sepsis Campaign guidelines

No new guidelines from tracked societies today. Ten journals swept with guideline title filters for 30 August – 1 September returned zero, all confirmed as genuine HTTP 200 responses rather than the silent failure that caught this morning’s literature run. Nothing dated 1 September on journal-watch. SFAR, SRLF, SPILF, ESAIC, ESICM, ESPEN, SCCM, EACTS, STS, IACTS and ASA all clear.

The search did surface something this archive should already have had, so the quiet day goes to filling that gap.

The 2026 Surviving Sepsis Campaign guidelines

Society · Published: Society of Critical Care Medicine and the European Society of Intensive Care Medicine. Critical Care Medicine, 23 March 2026 (DOI 10.1097/ccm.0000000000007075, PMID 41869847), with an Executive Summary alongside it and the same guideline in Intensive Care Medicine on 1 May (DOI 10.1007/s00134-026-08361-1). ~5 months old — not new, and never covered here.

Access note: no abstract is deposited for the adult guideline and the full text was not reachable. What follows about the adult document is drawn from ESICM’s own description and from published analyses of it, and is attributed as such. The paediatric guideline’s abstract is quoted directly.

Scale and structure

Per ESICM: 129 statements, 46 of them addressing questions not covered in 2021, developed by panels totalling over 130 experts from every continent, including patient and family representatives.

An analysis by Xue, Xie, Qiu and Liu (Zhonghua Yi Xue Za Zhi, June 2026) argues the substantive change is methodological rather than a list of new recommendations, describing four paradigm shifts:

• from evidence update to methodological restructuring
• from uniform recommendations to risk-stratified precision
• from acute-phase treatment to whole-course management
• from a high-resource centre perspective to global health equity, with an independent recommendation system for resource-limited settings

Changes reported

ESICM lists upgraded recommendations for prolonged β-lactam infusions, antimicrobial de-escalation, fluid resuscitation strategies, and dynamic measures to guide fluids.

The paediatric guideline, quoted directly

Its abstract is deposited in full, so this part is first-hand. A panel of 68 international experts from 13 organisations plus six methodologists, GRADE methodology, evidence-to-decision framework:

The panel provided 61 statements on the management of children with sepsis or septic shock. Overall, five were strong recommendations, 24 were conditional recommendations, and ten were good practice statements. For 22 PICO questions, no recommendations could be made, but for seven of these, “in our practice” statements were provided. Compared with the 2020 guidelines, 20 recommendations were new, 13 were updated for clarity and/or new evidence, six were reviewed but not changed, and 22 were carried forward.

A summary by Tripathy, Das and Ansari (Indian Pediatrics, June 2026) notes the paediatric version introduces the categories probable sepsis, suspected septic shock, and septic shock with persistent hypoperfusion, and highlights lactate at initial assessment, early antimicrobials, hospital performance-improvement programmes, cardiac and lung POCUS, a conservative oxygen strategy targeting SpO₂ 88–92%, and early rehabilitation.

Interpretation. Two things stand out.

First, the honesty of the numbers. Five strong recommendations out of 61 in the paediatric guideline, with 22 PICO questions yielding no recommendation at all, is a guideline panel declining to manufacture certainty. The “in our practice” device — guidance explicitly labelled as practice pattern rather than evidence — is a good innovation, and more useful than a conditional recommendation dressed up to look evidential.

Second, the prolonged β-lactam infusion thread. That upgrade closes a loop running through this week’s archive. The IDSA multisociety position paper on 29 August recommends defaulting antipseudomonal β-lactams to prolonged infusion; the French societies published their own recommendations on continuous and prolonged infusion in December 2024; and the Surviving Sepsis Campaign upgraded the same recommendation in March 2026. Three independent bodies, across roughly fifteen months, converging on the same change. If one thing from the last fortnight of guideline output is worth acting on locally, this is it.

The paediatric conservative oxygen target of 88–92% is the other item worth noting, given how contested conservative oxygen has been in adult critical care — where ICU-ROX, LOCO2 and HOT-ICU produced no consistent benefit and LOCO2 was stopped for harm. Seeing it as a paediatric recommendation is a stronger position than the adult evidence has ever supported.

Adult guideline · Executive summary · Paediatric guideline

A brand-new companion piece appeared yesterday — Kesecioglu, Metaxa and Azoulay, “Surviving Sepsis Campaign beyond survival: aligning sepsis care with patient goals,” Intensive Care Medicine, 31 August 2026, DOI 10.1007/s00134-026-08590-4. No abstract is deposited and the full text was not reachable, so it is noted rather than summarised.